Good day, and thank you for standing by. Welcome to the Taysha Gene Therapies Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is ...
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2025 Earnings Call Transcript March 17, 2026 Trevi Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.09657.
Achieved output of 50 Black Widow drones daily at Salt Lake facility, supporting capacity of 1,000 drones per month per shift ...
The following is the full transcript of the interview with International Atomic Energy Agency Director-General Rafael Grossi, ...
Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...
Real-time AI measurement investments established a new data capability by directly capturing user interactions with AI search ...
Historian Thomas Zimmer says Trump is still dangerous, but that his authoritarian project has been derailed on a number of fronts.
Nuwellis, Inc. beats earnings expectations. Reported EPS is $-1.4998, expectations were $-1.56. Operator: Thank you for your continued patience. Your meeting will begin shortly. If you need assistance ...
GAAP Net Income -- $110 million or $5.04 per share for the full year, reflecting a 175% increase. Adjusted Net Income -- $74 million or $3.04 per share for the full year, up $60 million, and a 429% ...
Jim Caruso, President and CEO, who will provide an overview of the company's progress before turning the call over to Chad Kolean, CFO, for a financial review of the quarter and the year. Following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results